Randomized Intervention Trial to Decrease Bisphenol A Urine Concentrations in Women: Pilot Study.

ENVIRONMENTAL exposure prevention; ANALYSIS of variance; BEHAVIOR therapy; BENZENE; CARDIOVASCULAR diseases risk factors; CONFIDENCE intervals; CREATININE; DIET; FOOD packaging; HIGH performance liquid chromatography; MASS spectrometry; PHENOLS; PROBABILITY theory; PILOT projects; BODY mass index; RANDOMIZED controlled trials; REPEATED measures design; DATA analysis software; DESCRIPTIVE statistics

Background: Previous studies have shown that women have higher concentrations of the endocrine disruptor bisphenol A (BPA), but an intervention to reduce BPA is lacking in women. To test the hypothesis that an intervention to reduce BPA would decrease urinary BPA concentrations over 3 weeks, 24 women (mean ± standard deviation [SD]; 22.1 ± 2.8 kg/m2 body mass index, 20.9 ± 1.5 years) were randomly assigned to an intervention or control. Materials and Methods: The intervention included weekly face-to-face meetings to reduce BPA exposures from food, cosmetics, and other packaged products. Women were provided with BPA-free cosmetics, hygiene, glass food/water containers, and daily self-monitored major sources of BPA. Fasting urine BPA and creatinine concentrations, and weight were assessed at study entry and after 3 weeks. Results: A significant ( p = 0.04) treatment × time interaction effect was observed on creatinine-adjusted BPA concentrations. From study entry to 3 weeks, women in the intervention significantly decreased geometric mean creatinine-adjusted urinary BPA by −0.71 ng/m, whereas women in the control significantly increased urinary BPA by 0.32 ng/mL ( p = 0.04). Additionally, from study entry to 3 weeks, women in the intervention significantly lost weight −0.28 ± 0.44 kg, whereas women in the control significantly gained weight +1.65 ± 0.74 kg ( p = 0.03). Changes in creatinine-adjusted BPA concentrations and weight were not significantly related ( p = 0.67). Conclusion: In this pilot study, a 3-week intervention decreased urinary BPA concentrations in women. Future clinical trials are needed to confirm these results and to examine whether a similar BPA intervention positively impacts risk markers in the pathogenesis of cardiovascular disease and diabetes. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Women's Health (15409996) is the property of Mary Ann Liebert, Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)